Literature DB >> 1915175

Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment.

C P Panayiotopoulos1, R Tahan, T Obeid.   

Abstract

Juvenile myoclonic epilepsy (JME), a common form of idiopathic generalized epilepsy, has a distinct clinical and electroencephalographic profile. Often JME is not recognized, with serious consequences on the sufferers. We examined factors contributing to the missed diagnosis even in an epilepsy clinic. Of 70 JME patients, 66 (91.4%) were not diagnosed on referral and 22 (33%) were not initially recognized in the epilepsy clinic. The correct diagnosis was established after a mean of 8.3 +/- 5.5 years from disease onset and an interval of 17.7 +/- 10.4 months from first evaluation in the epilepsy clinic. Myoclonic jerks, the hallmark of the disease, were not usually reported by patients. Similarly, relevant questioning may not be included in the history. Absence seizures antedating jerks by many years, myoclonic jerks reported as unilateral, generalized tonic-clonic seizures occurring during sleep and focal EEG abnormalities are other factors contributing to not recognizing JME. Our study reemphasizes the need to have not only a correct seizure diagnosis but also a correct epilepsy-disease diagnosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915175     DOI: 10.1111/j.1528-1157.1991.tb04708.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Neuropsychological deficits in childhood epilepsy syndromes.

Authors:  William S MacAllister; Sarah G Schaffer
Journal:  Neuropsychol Rev       Date:  2007-10-26       Impact factor: 7.444

Review 2.  Genetic generalized epilepsies in adults - challenging assumptions and dogmas.

Authors:  Bernd J Vorderwülbecke; Britta Wandschneider; Yvonne Weber; Martin Holtkamp
Journal:  Nat Rev Neurol       Date:  2021-11-26       Impact factor: 42.937

Review 3.  Topiramate for juvenile myoclonic epilepsy.

Authors:  Jia Liu; Yao-Jun Tai; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-11-24

4.  Focal interictal epileptiform discharges in idiopathic generalized epilepsy.

Authors:  Eman H Esmail; Amani M Nawito; Dalia M Labib; Mye A Basheer
Journal:  Neurol Sci       Date:  2016-03-08       Impact factor: 3.307

5.  Seizure aggravation by antiepileptic drugs.

Authors:  Ernest R Somerville
Journal:  Curr Treat Options Neurol       Date:  2006-07       Impact factor: 3.972

6.  Clinical and EEG characteristics of Juvenile Myoclonic Epilepsy.

Authors:  Khalid Sher; Rukhsana Abdul Sattar
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

7.  Juvenile Myoclonic Epilepsy in Rural Western India: Not Yet a Benign Syndrome.

Authors:  Devangi Desai; Soaham Desai; Trilok Jani
Journal:  Epilepsy Res Treat       Date:  2016-10-13

8.  Topiramate for juvenile myoclonic epilepsy.

Authors:  Jia Liu; Lu-Ning Wang; Yu-Ping Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-01-28

Review 9.  Seizure-Control Effect of Levatiracetam on Juvenile Myoclonic Epilepsy and Other Epileptic Syndromes: Literature Review of Recent Studies.

Authors:  Arsalan Hashemiaghdam; Amirsina Sharifi; Mojtaba Miri; Abbas Tafakhori
Journal:  Iran J Child Neurol       Date:  2015

10.  Two patients diagnosed with juvenile myoclonic epilepsy by first-ever status epilepticus in adult life.

Authors:  Hye Seon Jeong; Jeong Soo Moon; Eung Seok Oh; Jae Moon Kim
Journal:  J Epilepsy Res       Date:  2011-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.